Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: A prospective observational study

BMC Infectious Diseases

Volumn 7, Issue , 2007, Pages

  Mettler, Julian ^a   Simcock, Mathew ^a,b   Sendi, Pedram ^a,b   Widmer, Andreas F ^a   Bingisser, Roland ^a   Battegay, Manuel ^a   Fluckiger, Ursula ^a   Bassetti, Stefano ^a,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFEPIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; FLUCLOXACILLIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BILIARY TRACT INFECTION; BLOOD CULTURE; BONE INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; EMERGENCY WARD; EPIDIDYMITIS; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL INFECTION; HAEMOPHILUS INFLUENZAE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; INFECTIOUS ARTHRITIS; KLEBSIELLA PNEUMONIAE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PROSTATITIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SWITZERLAND; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION; TREATMENT FAILURE; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; URINE CULTURE; ADOLESCENT; AGED; DRUG THERAPY; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; OBSERVATION; PROSPECTIVE STUDY; STANDARD; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG THERAPY; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34147101314     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-7-21     Document Type: Article

References (28)

1. Mera RM Miller LA Daniels JJ Weil JG White AR Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project Diagn Microbiol Infect Dis 2005 51 195-200 15766606
2. Bratu S Landman D Haag R Recco R Eramo A Alam M Quale J Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium Arch Intern Med 2005 165 1430-1435 15983294
3. Oteo J Lazaro E de Abajo FJ Baquero F Campos J Antimicrobial-resistant invasive Escherichia coli, Spain Emerg Infect Dis 2005 11 546-553 15829192
4. Gould IM Antibiotic policies and control of resistance Curr Opin Infect Dis 2002 15 395-400 12130936
5. Neuhauser MM Weinstein RA Rydman R Danziger LH Karam G Quinn JP Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use Jama 2003 289 885-888 12588273
6. (WHO) WHO Hospitals: Recommendations for intervention. WHO global strategy for containment of antimicrobial resistance. Geneva, Switzerland, WHO 2001 26-35
7. Hecker MT Aron DC Patel NP Lehmann MK Donskey CJ Unnecessary use of antimicrobials in hospitalized patients: Current patterns of misuse with an emphasis on the antianaerobic spectrum of activity Arch Intern Med 2003 163 972-978 12719208
8. Kumarasamy Y Cadwgan T Gillanders IA Jappy B Laing R Gould IM Optimizing antibiotic therapy-the Aberdeen experience Clin Microbiol Infect 2003 9 406-411 12848753
9. Bugnon-Reber A de Torrente A Troillet N Genne D Antibiotic misuse in medium-sized Swiss hospitals Swiss Med Wkly 2004 134 481-485 15517500
10. Erbay A Colpan A Bodur H Cevik MA Samore MH Ergonul O Evaluation of antibiotic use in a hospital with an antibiotic restriction policy Int J Antimicrob Agents 2003 21 308-312 12672575
11. Hogerzeil HV Promoting rational prescribing: An international perspective Br J Clin Pharmacol 1995 39 1-6 7756093
12. Brown EM Interventions to optimise antibiotic prescribing in hospitals: the UK approach. Antibiotic policies: Theory and practice New York, Kluwer Academic/Plenum Publishers Gould IM and Meer JWM 2005 159-183
13. Solomon DH Van Houten L Glynn RJ Baden L Curtis K Schrager H Avorn J Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center Arch Intern Med 2001 161 1897-1902 11493132
14. Ruttimann S Keck B Hartmeier C Maetzel A Bucher HC Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital Clin Infect Dis 2004 38 348-356 14727204
15. Charlson ME Pompei P Ales KL MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation Journal of Chronic Diseases 1987 40 373-383 3558716
16. McCabe WR JGG Gram-negative bacteremia: I Etiology and ecology Arch Intern Med 1962 110 847-855
17. Berild D Ringertz SH Lelek M Appropriate antibiotic use according to diagnoses and bacteriological findings: Report of 12 point-prevalence studies on antibiotic use in a university hospital Scand J Infect Dis 2002 34 56-60 11874166
18. Porretta A Giuliani L Vegni FE Larosa M Privitera G Prevalence and patterns of antibiotic prescribing in Italian hospitals Infection 2003 31 Suppl 2 16-21 15018468
19. Bouza E Sousa D Munoz P Rodriguez-Creixems M Fron C Lechuz JG Bloodstream infections: A trial of the impact of different methods of reporting positive blood culture results Clin Infect Dis 2004 39 1161-1169 15486840
20. Cunney RJ McNamara EB Alansari N Loo B Smyth EG The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia J Clin Pathol 1997 50 1010-1012 500382 9516883
21. Munson EL Diekema DJ Beekmann SE Chapin KC Doern GV Detection and treatment of bloodstream infection: Laboratory reporting and antimicrobial management J Clin Microbiol 2003 41 495-497 149611 12517905
22. Thuong M Shortgen F Zazempa V Girou E Soussy CJ Brun-Buisson C Appropriate use of restricted antimicrobial agents in hospitals: The importance of empirical therapy and assisted re-evaluation J Antimicrob Chemother 2000 46 501-508 10980183
23. Senn L Burnand B Francioli P Zanetti G Improving appropriateness of antibiotic therapy: Randomized trial of an intervention to foster reassessment of prescription after 3 days J Antimicrob Chemother 2004 53 1062-1067 15128726
24. Heer T Schiele R Schneider S Gitt AK Wienbergen H Gottwik M Gieseler U Voigtlander T Hauptmann KE Wagner S Senges J Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry) Am J Cardiol 2002 89 511-517 11867033
25. Kucher N Tapson VF Quiroz R Mir SS Morrison RB McKenzie D Goldhaber SZ Gender differences in the administration of prophylaxis to prevent deep venous thrombosis Thromb Haemost 2005 93 284-288 15711744
26. Ferrara A Williamson DF Karter AJ Thompson TJ Kim C Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes: The translating research into action for Diabetes (TRIAD) study, 2000-2001 Diabetes Care 2004 27 2974-2976 15562217
27. Gebo KA Fleishman JA Conviser R Reilly ED Korthuis PT Moore RD Hellinger J Keiser P Rubin HR Crane L Hellinger FJ Mathews WC Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001 J Acquir Immune Defic Syndr 2005 38 96-103 15608532
28. Norris P Becket G Ecke D Demographic variation in the use of antibiotics in a New Zealand town N Z Med J 2005 118 U1352 15778753